Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs To Use IG's ERGO Software

NEW YORK (GenomeWeb News) - New England Biolabs has licensed Integrated Genomics' ERGO software for gene annotation, metabolic reconstruction, enzyme data mining and comparative genomics research, IG said yesterday.
 
IG said the ERGO platform integrates data from various types of studies, including genomics, biochemistry, gene expression studies, genetics and literature.
 
The company said ERGO contains more than 1,180 genomes at “various stages of completion," as well as a network of cellular pathways.
 
New England Biolabs is a private company that offers recombinant and native enzymes for DNA analysis, genomics, and proteomics.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.